Loading…
Loading…
Yes. Aurobindo Pharma USA, Inc. sponsors both H-1B visas and green cards. Since October 2021 it filed 39 (39 certified) and 9 (8 certified, 0 denied). The latest decision in our data is from Sep 10, 2026.
Decisions by U.S. government fiscal year (October to September).
| H-1B | Certified | Median salary | PERM cases | PERM denied | PERM median days | |
|---|---|---|---|---|---|---|
| FY2026 | 9 | 9 | $120,000 | 3 | 0 | 3023 cases |
| FY2025 | 12 | 12 | $96,300 | 1 | 0 | 4641 case |
| FY2024 | 4 | 4 | $116,600 | 2 | 0 | 3841 case |
| FY2023 | 4 | 4 | $119,891 | 1 | 0 | 2721 case |
| FY2022 | 10 | 10 | $71,604 | 2 | 0 | 1662 cases |
By standard occupation code, all filings since FY2022.
| Occupation () | H-1B | Median salary | PERM cases |
|---|---|---|---|
| Financial Managers (11-3031) | 9 | $180,066 | 2 |
| Regulatory Affairs Specialists (13-1041) | 4 | $64,355 | 1 |
| Chemists (19-2031) | 4 | $64,293 | 1 |
| Logisticians (13-1081) | 4 |
Worksite state, all filings since FY2022.
| State | H-1B | Median salary | PERM cases |
|---|---|---|---|
| New Jersey | 34 | $108,000 | 8 |
| North Carolina | 4 | $64,293 | 1 |
| Florida | 1 | $98,000 | 0 |
Download all 39 H-1B filings as CSV (Pro): job titles, worksites, offered and prevailing wages.
Source: DOL OFLC LCA and PERM disclosure data, FY2022 to FY2026. Filings are grouped by the employer's legal name, so subsidiaries such as separate LLCs appear as separate employers. Salaries are the offered wage on certified LCAs, converted to a yearly amount. See also PERM processing times.
| $80,000 |
0 |
| Accountants and Auditors (13-2011) | 4 | $80,000 | 0 |
| Software Developers (15-1252) | 3 | $91,900 | 1 |
| Management Analysts (13-1111) | 2 | $71,604 | 1 |
| Financial and Investment Analysts (13-2051) | 2 | $98,000 | 0 |
| Chemical Engineers (17-2041) | 1 | $108,000 | 1 |
| Mechanical Engineers (17-2141) | 1 | $116,600 | 1 |